Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.53)
# 1,033
Out of 4,572 analysts
717
Total ratings
43.5%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $13.66 | - | 33 | Jul 24, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $125 | $56.55 | +121.04% | 28 | Jul 23, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $95 | $81.93 | +15.95% | 58 | Jul 21, 2026 | |
| INCY Incyte | Reiterated: Buy | $140 | $117.67 | +18.98% | 15 | Jul 21, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $45 | $28.82 | +56.14% | 2 | Jul 21, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 550.00 → kr 575.00 | kr 457.40 | +25.71% | 5 | Jul 17, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Hold | n/a | $16.30 | - | 8 | Jul 16, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $65 | $22.22 | +192.53% | 61 | Jul 16, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | $50 | $59.33 | -15.73% | 11 | Jul 14, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $80 | $46.54 | +71.90% | 17 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.77 | +69.92% | 4 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $15.68 | -68.11% | 32 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.95 | +258.97% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $34.90 | +100.57% | 34 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.36 | - | 6 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $92.16 | +30.21% | 17 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $10.73 | +132.99% | 15 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $12.63 | +256.29% | 24 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.41 | +237.38% | 20 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.60 | +92.31% | 9 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.88 | +217.26% | 23 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $10.64 | +40.98% | 22 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.11 | +136.97% | 28 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 | $28.00 | -10.71% | 22 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $35 | $18.44 | +89.80% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $30.63 | +46.91% | 35 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $3.24 | +239.51% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $25 | $13.40 | +86.57% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $4.66 | +114.59% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.13 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.57 | +55.64% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.21 | +480.91% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $5.23 | -61.76% | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $5.94 | +320.88% | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.31 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0045 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8509 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.05 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $4.12 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.46 | n/a | 8 | Aug 11, 2023 |
Summit Therapeutics
Jul 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.66
Upside: -
Ionis Pharmaceuticals
Jul 23, 2026
Reiterated: Buy
Price Target: $125
Current: $56.55
Upside: +121.04%
Halozyme Therapeutics
Jul 21, 2026
Reiterated: Buy
Price Target: $95
Current: $81.93
Upside: +15.95%
Incyte
Jul 21, 2026
Reiterated: Buy
Price Target: $140
Current: $117.67
Upside: +18.98%
Damora Therapeutics
Jul 21, 2026
Reiterated: Buy
Price Target: $45
Current: $28.82
Upside: +56.14%
Swedish Orphan Biovitrum AB (publ)
Jul 17, 2026
Reiterated: Buy
Price Target: kr 550.00 → kr 575.00
Current: kr 457.40
Upside: +25.71%
Crescent Biopharma
Jul 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.30
Upside: -
Legend Biotech
Jul 16, 2026
Reiterated: Buy
Price Target: $65
Current: $22.22
Upside: +192.53%
BioMarin Pharmaceutical
Jul 14, 2026
Reiterated: Hold
Price Target: $50
Current: $59.33
Upside: -15.73%
CRISPR Therapeutics AG
Jul 8, 2026
Reiterated: Buy
Price Target: $80
Current: $46.54
Upside: +71.90%
Jul 8, 2026
Reiterated: Buy
Price Target: $20
Current: $11.77
Upside: +69.92%
Jul 1, 2026
Reiterated: Sell
Price Target: $5
Current: $15.68
Upside: -68.11%
Jun 30, 2026
Reiterated: Buy
Price Target: $7
Current: $1.95
Upside: +258.97%
Jun 30, 2026
Reiterated: Buy
Price Target: $70
Current: $34.90
Upside: +100.57%
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.36
Upside: -
Jun 23, 2026
Reiterated: Buy
Price Target: $120
Current: $92.16
Upside: +30.21%
Jun 15, 2026
Reiterated: Buy
Price Target: $25
Current: $10.73
Upside: +132.99%
Jun 9, 2026
Reiterated: Buy
Price Target: $45
Current: $12.63
Upside: +256.29%
Jun 4, 2026
Reiterated: Buy
Price Target: $25
Current: $7.41
Upside: +237.38%
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $2.60
Upside: +92.31%
May 26, 2026
Maintained: Buy
Price Target: $25
Current: $7.88
Upside: +217.26%
May 26, 2026
Maintained: Buy
Price Target: $15
Current: $10.64
Upside: +40.98%
May 26, 2026
Reiterated: Buy
Price Target: $5
Current: $2.11
Upside: +136.97%
May 15, 2026
Downgraded: Hold
Price Target: $25
Current: $28.00
Upside: -10.71%
May 14, 2026
Reiterated: Buy
Price Target: $40 → $35
Current: $18.44
Upside: +89.80%
May 14, 2026
Reiterated: Buy
Price Target: $45
Current: $30.63
Upside: +46.91%
May 11, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $3.24
Upside: +239.51%
May 8, 2026
Rated: Buy
Price Target: $16 → $25
Current: $13.40
Upside: +86.57%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $4.66
Upside: +114.59%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.13
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.57
Upside: +55.64%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.21
Upside: +480.91%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $5.23
Upside: -61.76%
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $5.94
Upside: +320.88%
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $16.31
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0045
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.8509
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $6.05
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $4.12
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $1.46
Upside: n/a